Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if the combination of bendamustine, lenalidomide and
dexamethasone will help people with multiple myeloma that has returned after standard
treatment or has been resistant to other treatments.